Patent · US Active

Using nucleosome interacting protein domains to enhance targeted genome modification

US12221606B2 · kind B2 · utility

0Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 18, 2020
Grant dateFeb 11, 2025
Priority date
Expiry dateMay 13, 2043

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for using nucleosome interacting protein domains to increase accessibility of programmable DNA modification proteins to target chromosomal sequences, thereby increasing efficiency of targeted genome/epigenetic modification in eukaryotic cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.